Xellia (Taizhou) Pharmaceuticals Co., Ltd. [Jiaojiang Shi / China]
Xellia (Taizhou) Pharmaceuticals Co., Ltd. [Jiaojiang Shi / China] located in JIAOJIANG SHI ZHEJIANG, China under the [Novo Holdings] organization had its last known inspection on 18 Jan 2023. There are 7 known inspections on record.
        Site Details
                        Industries:
                    
                    
                                Human Drugs,
                                Animal Health
                        
                    
                        Tags:
                    
                    
                                FDF Manufacturer,                                
                                Packaging,                                
                                API Manufacturer,                                
                                Analytical Testing,                                
                                Animal Health,                                
                                Human Drugs,                                
                                Animal Health: Animal Drugs,                                
                                Repackaging                                
                        
                    
                        Parent Organization:
                    
                    Novo Holdings
                
                        Last Inspection Date:
                    
                    18 Jan 2023
                
                        FEI:
                    
                    3007422723
                
                        Redica ID:
                    
                    
                
                        Investigators:
                    
                    
                Xellia (Taizhou) Pharmaceuticals Co., Ltd. [Jiaojiang Shi / China]'s Most Recent Documents
| Publish Date | Document Type | Title | 
|---|---|---|
| April, 2018 | EIR | Xellia (Taizhou) Pharmaceuticals Co., Ltd. - EIR, 2018-04-06 | 
| April, 2018 | FDA 483 | Xellia (Taizhou) Pharmaceuticals Co., Ltd. - Form 483, 2018-04-06 | 
Experience Redica Systems’ NEW site dashboards and profiles
Redica Systems customers can leverage the full Quality and Regulatory Intelligence suite, with powerful analysis covering thousands of sites around the world. You can search by FEI, or more powerfully, by the Redica ID, our universal identifier for global life sciences manufacturing sites, an industry first.
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
                    Loading...
Site Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to our extensive inventory of site profiles, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
 - The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
 - Latest 483s: see what the trends are across all FDA Investigators
 - CFR Heatmap: Citations aggregated by Subpart by Year
 
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
 - All of the functionality mentioned above but isolated to just your vendors
 
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
 - All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more